Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advanced NanoBiomed Research is Scopus-indexed (Q1, CiteScore 8.8), WoS ESCI, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 2699-9307Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 49 / 466 | 89th | Q1 |
| Engineering (miscellaneous) | 35 / 300 | 88th | Q1 |
| Applied Microbiology and Biotechnology | 26 / 134 | 80th | Q1 |
| Biomaterials | 42 / 146 | 71st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q1, CiteScore 8.8.
Advanced NanoBiomed Research is Q1 in Medicine (miscellaneous) (rank 49 of 466), Q1 in Engineering (miscellaneous) (rank 35 of 300) and Q1 in Applied Microbiology and Biotechnology (rank 26 of 134), by CiteScore 2025. It is ranked in 4 subject areas in all.
Advanced NanoBiomed Research is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.8, which places it in quartile Q1 at the 89th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.058, quartile Q1, with an H-index of 31.
The publisher lists an article processing charge of about US$3,940 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Advanced NanoBiomed Research is published by John Wiley and Sons Inc. Its ISSN is 2699-9307.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Advanced NanoBiomed Research has an h-index of 38 and a 2-year mean of 3.37 citations per paper (OpenAlex). Its Scopus CiteScore is 8.8, quartile Q1. On 2-year citations it ranks #88 of 451 Scopus journals in Medicine (miscellaneous).
Advanced NanoBiomed Research published 138 papers in 2025; its busiest recent year was 2021 with 169. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from Australia (18.7%), United States (17.3%) and China (14.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.